Management of Buruli ulcer–HIV coinfection Technical update Contents

First Page		Document Content
Date: 2015-03-05 19:03:57 HIV/AIDS Infectious diseases Tropical diseases Microbiology Buruli ulcer Mycobacterium ulcerans Antiretroviral drug HIV AIDS Medicine Health Biology		Management of Buruli ulcer–HIV coinfection Technical update Contents Add to Reading List Source URL: apps.who.int Download Document from Source Website File Size: 1,47 MB Share Document on Facebook

	PRESS RELEASE Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF BETHLEHEM, PA- October 10, 2012 ‐ Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of a DocID: 1m6of - View Document
	Microsoft Word - Biographie de JF Delfraissy BIS.doc DocID: 1gw3d - View Document
	Surveillance and outbreak reports Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S DocID: 1gvMD - View Document
	Questioning the HIV-AIDS hypothesis: 30 years of dissent DocID: 1gtoc - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas DocID: 1gtlL - View Document